| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Timothy R Wright last filed a Form 4 in March 2024, as Chief Executive Officer at MDXG. Timothy R Wright's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Timothy R Wright a middling insider score of 52/100, based on 4 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +3.0%.
At the last filing, the largest reported position was 1,711,324 shares of MDXG. The MDXG filings lean toward selling, a net 320,568 shares.
Timothy R Wright has 11 Form 4 filings on record from June 2019 to March 2024, across 2 companies: Director at Protagenic Therapeutics, Inc.\new (PTIX), 2024; Chief Executive Officer at Mimedx Group (MDXG), 2019–2022.
The 11 reported transactions were 4 open-market sales, 4 stock awards, 2 tax withholdings and 1 option or other derivative award.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $905K.
The largest open-market sale was 112,000 shares of MDXG at an average $3.75 on June 9, 2022, about $420K. Twelve months later MDXG was up 66%.
Shares as reported in the last Form 4 for each company; the most recent is from March 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2022 | MDXG Mimedx Group, Inc. | Chief Executive Officer | Sell | 112,000 | $3.75 | $420,000.00 | -6.1% | -4.0% | +65.5% | |
| Mar 8, 2022 | MDXG Mimedx Group, Inc. | Chief Executive Officer | Sell | 45,611 | $4.86 | $221,623.85 | -3.6% | -19.7% | -15.5% | |
| Feb 23, 2022 | MDXG Mimedx Group, Inc. | Chief Executive Officer | Sell | 61,000 | $4.31 | $263,074.70 | -4.6% | -21.8% | +2.3% | |
| Jun 8, 2021 | MDXG Mimedx Group, Inc. | Chief Executive Officer | Sell | 101,957 | $0.00 | - | -7.1% | +45.6% | -64.2% |